Nature Metrics Ltd
Registered name: NATURE METRICS LTD
Nature Metrics Ltd made £4.4m revenue and a £8.2m loss in the year to 31 Dec 2025.
Nature Metrics Ltd’s revenue fell 18% to £4.4m in the year to 31 Dec 2025, with a loss of £8.2m and 109 employees. The company is classified under “research and experimental development on biotechnology” and is based in Guildford; we hold 5 years of its filed accounts.
- Status
- Active
- Location
- Guildford, South East
- Age
- 12 yrs · since 2014
- Type
- Private Limited Company
Key figures
Badges are automated estimates derived from the filed figures — not statements of fact about the company.
Financial history
| Year to | 31 Dec 2021 | 31 Dec 2022 | 31 Dec 2023 | 31 Dec 2024 | 31 Dec 2025 |
|---|---|---|---|---|---|
| Disclosure | Full P&L | Full P&L | Full P&L | Full P&L | Full P&L |
| Profit & loss | |||||
| Revenue (turnover) | £2.2m | £4.1m | £5.7m | £5.3m | £4.4m |
| Cost of sales | £990k | £2.9m | £3m | £2.6m | £2.3m |
| Gross profit | £1.2m | £1.2m | £2.6m | £2.7m | £2m |
| Operating profit | −£3.4m | −£7.8m | −£9.3m | −£9.6m | −£8.7m |
| Profit before tax | −£3.4m | −£7.9m | −£9.2m | −£9.7m | −£8.4m |
| Profit after tax | −£3.2m | −£6.9m | −£8.1m | −£8.6m | −£8.2m |
| Profit (best available) | −£3.2m | −£6.9m | −£8.1m | −£8.6m | −£8.2m |
| Staff costs | £2.7m | £6.1m | £8.6m | £8.9m | £8m |
| Employees (average) | 56 | 107 | 140 | 133 | 109 |
| Ratios | |||||
| Profit margin | −148.7% | −166.8% | −143.7% | −161.4% | −186.6% |
| Gross margin | 54.7% | 28.9% | 46.3% | 50.8% | 46.7% |
| Revenue per employee | £39k | £38.5k | £40.5k | £40.1k | £40.2k |
| Profit per employee | −£58k | −£64.2k | −£58.2k | −£64.8k | −£74.9k |
| Growth (year on year) | |||||
| Revenue growth | — | ▲88.6% | ▲37.7% | ▼5.9% | ▼18% |
| Headcount growth | — | ▲91.1% | ▲30.8% | ▼5% | ▼18.1% |
| Balance sheet — indirect signals, not revenue | |||||
| Cash at bank | £3.7m | £6.5m | £7.4m | £3m | £11m |
| Net assets | £5.1m | £10.1m | £11.1m | £2.7m | £14.7m |
| Fixed assets | £1.7m | £2m | £1.7m | £1.2m | £1.2m |
| Current assets | £5.6m | £10.8m | £13m | £8.3m | £16.5m |
| Debtors | £721k | £741k | £1.7m | £827k | £985k |
| Deferred income | £606k | £721k | £1.4m | £1.3m | £1.5m |
| Cash from operations | −£2.5m | −£8.2m | −£8.9m | −£7.8m | −£8.8m |
| Source | Accounts · bulk data Oct 2023 | Accounts · bulk data Oct 2023 | FullAccounts · bulk data Jan 2025 | FullAccounts · bulk data Sep 2025 | FullAccounts · bulk data Sep 2026 |
How the business works
- Profit margin
- −186.6%
- Profit ÷ revenue.
- Gross margin
- 46.7%
- Gross profit ÷ revenue. High for software and services.
- Revenue per employee
- £40.2k
- Revenue ÷ average employees.
- Profit per employee
- −£74.9k
- Profit ÷ average employees.
- Cash conversion
- —
- Cash generated from operations ÷ operating profit. Needs a cash-flow statement.
- Fixed assets ÷ revenue
- 27.5%
- Capital intensity. Low = capital-light, cheaper to start.
- Deferred income ÷ revenue
- 35.3%
- Customers paying upfront (subscriptions, deposits). Approximate when combined with accruals.
- Debtors ÷ revenue
- 22.5%
- Money owed by customers. Low = customers pay quickly.
Balance-sheet signals
Year-on-year changes in filed balance-sheet items. They can hint at momentum (or investment) but are not revenue or profit and must not be read as such.
- Net assets
- ▲439%
- Now £14.7m
- Cash at bank
- ▲270%
- Now £11m
- Headcount
- ▼18%
- Now 109
- Deferred income
- ▲18%
- Now £1.5m
- Fixed assets
- ▼2%
- Now £1.2m
Similar profitable businesses
- Takara Bio UK LtdLondon · Research and experimental development on biotechnology
- Revenue
- £3.1m
- Profit
- £97.2k
- Staff
- 9
- Clinuvel (UK) LimitedLondon · Research and experimental development on biotechnology
- Revenue
- £6.4m
- Profit
- £81.6k
- Staff
- 46
- Ligand UK Development LimitedLondon · Research and experimental development on biotechnology
- Revenue
- £8.7m
- Profit
- £6m
- Staff
- —
- Flatiron Health UK LtdST Albans · Research and experimental development on biotechnology
- Revenue
- £9.5m
- Profit
- £239k
- Staff
- 32
- Biopharma Process Systems LimitedWinchester · Research and experimental development on biotechnology
- Revenue
- £10.1m
- Profit
- £142k
- Staff
- 66
- Askbio UK LtdMidlothian · Research and experimental development on biotechnology
- Revenue
- £12.5m
- Profit
- £1.8m
- Staff
- 54
Sources
Latest figures from FullAccounts for the year to 31 Dec 2025 (profit −£8.2m), from the Companies House accounts bulk data published Sep 2026. Spotted an error? Request a correction.
Contains public sector information from Companies House licensed under the Open Government Licence v3.0. Data from Companies House, © Crown copyright. View the licence.